Xxera/openscience/retractions

Record #70216

CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway

Meng-Yao Sun, Su-Juan Wang, Xiao-Qin Li, Yu-Li Shen, Jian-Rao Lu, Xin-Hui Tian, Khalid Rahman, Li-Jun Zhang, Hua Nian, Hong Zhang

Journal

Frontiers in Pharmacology

Publisher

Original paper date

Mar 25, 2019

Original DOI

10.3389/fphar.2019.00224

Country

🇨🇳 China · 🇬🇧 United Kingdom

Institution

Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China · Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China · Department of Drug Preparation, Hospital of TCM and Hui Nationality Medicine, Ningxia Medical University, Wuzhong, China · Department of Nephrology, Seventh People’s Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China · School of Pharmacy and Biomolecular Sciences, Faculty of Science, Liverpool John Moores University, Liverpool, United Kingdom · Department of Pharmacy, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Open access

No

Article type

Research Article

Broad categories

(BLS) Biology - Cellular (BLS) Genetics (HSC) Medicine - Diabetes (HSC) Medicine - Pathology (HSC) Medicine - Urology/Nephrology

Notes from Retraction Watch

See also: https://pubpeer.com/publications/BA743618D3EF58AFDF68D70903D7E1

Citation lifecycle

How this paper is being cited

Pre-retraction

50

Same day

0

Post-retraction

7

% post-retraction

12.3%

~8.8 citations/yr before retraction · ~3.9 citations/yr after

— citing papers

Who is still citing this work

Loading…